Kamada KMDA
NASDAQ KMDA
$8.69 +0.07 (+0.87%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kamada (KMDA) Gross Margin (2012 - 2026)

Updated

Kamada's Gross Margin came in at 40.91% for the quarter ended Jun 30, 2026, down 1.39 percentage points from 42.30% a year earlier and down 1.35 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Gross Margin (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Kamada reported Gross Margin of 40.82%, down 2.80 percentage points year-over-year; for the year ended Dec 31, 2025, it was 42.34%, down 1.13 percentage points from the prior year.

  • Gross Margin carries a five-year change of +6.65 percentage points (years ended Dec 2020 to Dec 2025).
  • Going back by year, Gross Margin was 43.47% in the year ended Dec 31, 2024 (+4.54 pp), 38.94% in the year ended Dec 31, 2023 (+2.83 pp), 36.11% in the year ended Dec 31, 2022 (+6.85 pp) and 29.26% in the year ended Dec 31, 2021 (-6.43 pp).
  • The five-year range for quarterly Gross Margin is 20.96% (the quarter ended Dec 31, 2021) to 47.14% (the quarter ended Mar 31, 2025).
  • Year-over-year, Gross Margin has declined for three consecutive quarters, with an average year-over-year change of -0.55 percentage points over the last eight quarters.
  • The fastest year-over-year change in Gross Margin over five years came in the quarter ended Sep 30, 2022 (a gain of 15.07 percentage points), and the weakest in the quarter ended Sep 30, 2021 (a drop of 17.08 percentage points).
  • Business Quant data shows KMDA's Gross Margin at 42.25% (quarter ended Mar 31, 2026), 37.98% (quarter ended Dec 31, 2025) and 42.04% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Kamada 497.25 Mn 206.31 Mn 22.47 Mn 40.91%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.91%
Mar 31, 2026 42.25%
Dec 31, 2025 37.98%
Sep 30, 2025 42.04%
Jun 30, 2025 42.30%
Mar 31, 2025 47.14%
Dec 31, 2024 43.66%
Sep 30, 2024 41.29%
Jun 30, 2024 44.62%
Mar 31, 2024 44.39%
Dec 31, 2023 39.56%
Sep 30, 2023 39.02%
Jun 30, 2023 38.55%
Mar 31, 2023 38.55%
Dec 31, 2022 33.65%
Sep 30, 2022 39.95%
Jun 30, 2022 30.69%
Mar 31, 2022 40.23%
Dec 31, 2021 20.96%
Sep 30, 2021 24.88%
API Access

Kamada Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=KMDA&period=max&api_key=YOUR_API_KEY